- Home
- ICAD vs KRON Comparison
ICAD vs KRON Comparison
Compare ICAD & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- KRON
- Stock Information
- Founded
- ICAD 1984
- KRON 2017
- Country
- ICAD United States
- KRON United States
- Employees
- ICAD N/A
- KRON N/A
- Industry
- ICAD Medical/Dental Instruments
- KRON Medicinal Chemicals and Botanical Products
- Sector
- ICAD Health Care
- KRON Health Care
- Exchange
- ICAD Nasdaq
- KRON Nasdaq
- Market Cap
- ICAD 40.8M
- KRON 60.3M
- IPO Year
- ICAD 1986
- KRON 2020
- Fundamental
- Price
- ICAD $1.95
- KRON $0.93
- Analyst Decision
- ICAD
- KRON Strong Buy
- Analyst Count
- ICAD 0
- KRON 2
- Target Price
- ICAD N/A
- KRON $4.13
- AVG Volume (30 Days)
- ICAD 144.4K
- KRON 59.4K
- Earning Date
- ICAD 11-11-2024
- KRON 11-11-2024
- Dividend Yield
- ICAD N/A
- KRON N/A
- EPS Growth
- ICAD N/A
- KRON N/A
- EPS
- ICAD N/A
- KRON N/A
- Revenue
- ICAD $18,795,000.00
- KRON $8,412,000.00
- Revenue This Year
- ICAD $13.15
- KRON $52.58
- Revenue Next Year
- ICAD $24.28
- KRON N/A
- P/E Ratio
- ICAD N/A
- KRON N/A
- Revenue Growth
- ICAD 7.40
- KRON 172.76
- 52 Week Low
- ICAD $1.18
- KRON $0.69
- 52 Week High
- ICAD $2.65
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- ICAD 70.48
- KRON 44.01
- Support Level
- ICAD $1.34
- KRON $0.85
- Resistance Level
- ICAD $2.10
- KRON $0.97
- Average True Range (ATR)
- ICAD 0.12
- KRON 0.06
- MACD
- ICAD 0.04
- KRON -0.00
- Stochastic Oscillator
- ICAD 80.26
- KRON 43.82
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.